Equity Capital Markets

Alnylam Pharmaceuticals, Inc.

11/17
|
$805.0 Million
Piper Sandler served as co-manager for Alnylam Pharmaceuticals, Inc on a follow-on offering
Sub-Type
Follow-On Offering
Sector
Healthcare
Sub-Sector
Biopharma

Related Transactions

All Transactions
$316.2 Million
ANI
Convertible Offering
Active Bookrunner
$175.0 Million
Day One
PIPE
Joint Placement Agent
$230.0 Million
Renasant Corp.
Follow-On Offering
Co-Manager
$5.1 Billion
Lineage Logistics, LLC
Lineage Logistics, LLC
Initial Public Offering
Passive Bookrunner
$563.5 Million
One Stream
OneStream Software
Initial Public Offering
Passive Bookrunner
$215.0 Million
TWFG
The Woodlands Financial Group
Initial Public Offering
Active Bookrunner
$283.5 Million
LandBridge
Initial Public Offering
Passive Bookrunner
$92.0 Million
Abacus Life
Abacus Life, Inc.
Follow-On Offering
Left Bookrunner
$80.0 Million
Sound Point Meridian Capital, Inc.
Sound Point Meridian Capital, Inc.
Initial Public Offering
Active Bookrunner
$163.4 Million
JAMF
JAMF Software, LLC
Confidentially Marketed Follow-On Offering
Co-Manager
$103.2 Million
Merchants Bancorp
Merchants Bancorp
Confidentially Marketed Follow-On Offering
Passive Bookrunner
$250.0 Million
Pacira BioSciences, Inc.
Pacira BioSciences, Inc.
Senior Note Offering
Passive Bookrunner
$184.7 Million
Skyward Specialty Insurance
Skyward Specialty Insurance
Follow-On Offering
Passive Bookrunner
$100.0 Million
Context Therapeutics LLC
Context Therapeutics LLC
PIPE
Sole Placement Agent
$138.0 Million
Soleno Therapeutics, Inc.
Soleno Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
$241.5 Million
UMB Financial Corporation
UMB Financial Corporation
Confidentially Marketed Follow-On Offering
Co-Manager

© 2024 Piper Sandler Companies. Since 1895. All rights reserved.